Can a smartphone app ease the burden of chronic GVHD?
NCT ID NCT05690971
First seen Nov 18, 2025 · Last updated May 19, 2026 · Updated 18 times
Summary
This study tests a mobile app called Horizons designed to help people with chronic graft-versus-host disease (GVHD) cope better and improve their quality of life. About 120 adults who had a stem cell transplant and now have moderate to severe chronic GVHD will use the app or receive usual care. The goal is to see if the app reduces symptoms and distress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.